Reed Smith LLP

Reed Smith advises Nextmune, a portfolio company of Fidelio Capital, on its acquisition of U.S. Veterinary Allergy Testing and Treatment Activities from ALK

Home Neuigkeiten Reed Smith advises Nextmune, a portfolio company of Fidelio Capital, on its acquisition of U.S. Veterinary Allergy Testing and Treatment Activities from ALK
New York, NY - Global law firm Reed Smith today announced that it represented Sweden-based Nextmune, a portfolio company of Fidelio Capital and the global leader in companion-animal allergy testing on the closing of its acquisition of the U.S. veterinary business activities known as ACTT from ALK, a global, research-driven pharmaceutical company that focuses on prevention, diagnosis, and treatment of allergies.

Rechtsanwälte: Christopher M. Sheaffer Anatoliy Rozental Nataly R. Laufer Sultan Sophie Ha

The Reed Smith Private Equity team on this transaction was comprised of Christopher Sheaffer, Anatoliy Rozental, Nataly Laufer Sultan and Sophie Ha.

For a copy of the press release issued by Nextmune announcing the acquisition, visit businesswire.com.

About Reed Smith

Reed Smith is a dynamic international law firm dedicated to helping clients move their businesses forward. Our belief is that by delivering smarter and more creative legal services, we will not only enrich our clients’ experiences with us, but also support them in achieving their business goals.

Our long-standing relationships, international outlook, and collaborative structure make us the go-to partner for the speedy resolution of complex disputes, transactions, and regulatory matters.

For further information, please visit reedsmith.com.

Das könnte Sie auch interessieren

Structuring property partnerships and joint ventures
29 January 2020
Reed Smith's FinTech offering ranked by Chambers
23 January 2020
Final CFIUS regulations set stage for new era of national security reviews
Reed Smith Client Alerts
22 January 2020
Reed Smith expands in Europe with Brussels office launch
16 January 2020